The financing comes on top of the company's $900 million annual research and development investment in the U.S.

Add MobiHealthNews to your network.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combatting the FDA’s claim that it qualifies as a regulated medical device.

Kenrick Cato, nurse scientist, pediatric data and analytics, Children's Hospital of Philadelphia, says that nurses are ...